JNGLX
Price
$67.12
Change
+$0.48 (+0.72%)
Updated
Jul 14 closing price
Net Assets
4.4B
LHCVX
Price
$18.75
Change
+$0.16 (+0.86%)
Updated
Jul 14 closing price
Net Assets
7.29M
Interact to see
Advertisement

JNGLX vs LHCVX

Header iconJNGLX vs LHCVX Comparison
Open Charts JNGLX vs LHCVXBanner chart's image
Janus Henderson Global Life Sciences D
Price$67.12
Change+$0.48 (+0.72%)
VolumeN/A
Net Assets4.4B
Lord Abbett Health Care R6
Price$18.75
Change+$0.16 (+0.86%)
VolumeN/A
Net Assets7.29M
JNGLX vs LHCVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JNGLX vs. LHCVX commentary
Jul 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and LHCVX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.4B vs. LHCVX (7.29M). LHCVX pays higher dividends than JNGLX: LHCVX (0.58) vs JNGLX (0.36). JNGLX was incepted earlier than LHCVX: JNGLX (27 years) vs LHCVX (6 years). LHCVX (2.99) is less costly to investors than JNGLX (0.80). LHCVX is a more actively managed with annual turnover of: 88.00 vs. JNGLX (35.00). LHCVX has a lower initial minimum investment than JNGLX: LHCVX (0) vs JNGLX (2500). LHCVX annual gain was more profitable for investors over the last year : -9.19 vs. JNGLX (-15.38). JNGLX return over 5 years is better than : 3.70 vs. LHCVX (2.13).
JNGLXLHCVXJNGLX / LHCVX
Total Expense Ratio0.800.68118%
Annual Report Gross Expense Ratio0.802.9927%
Fund Existence27 years6 years-
Gain YTD-1.134-4.32326%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.4B7.29M60,384%
Annual Yield % from dividends0.360.5861%
Returns for 1 year-15.38-9.19167%
Returns for 3 years9.579.6899%
Returns for 5 years3.702.13174%
Returns for 10 years6.15N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NOLCX30.64N/A
N/A
Northern Large Cap Core
FINSX48.14N/A
N/A
Fidelity Advisor New Insights I
FFACX16.14N/A
N/A
Franklin Global Allocation C
JUSPX16.88N/A
N/A
JPMorgan US Small Company R3
SIFZX24.94N/A
N/A
Saturna International Z